|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's range||6.45 - 6.99|
|52-week range||6.12 - 31.53|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||25.75|
Regulatory and other pipeline updates from Biogen (BIIB) and AMGN are among a few key highlights from the biotech sector during the past week.
Absci (ABSI) signs a deal with Merck for using its AI-powered drug creation platform to produce enzymes for Merck's biomanufacturing applications with an option for the development of three novel drugs.
The stock market looked like it would open on a quiet note on Friday, as investors looked to digest the latest jobs report. S&P 500 (SNPINDEX: ^GSPC) futures had fallen 2 points to 4,685, while Nasdaq Composite (NASDAQINDEX: ^IXIC) futures had dropped 22 points to 15,737. STMicroelectronics (NYSE: STM) has recently climbed to levels it hasn't seen since the tech boom of the late 1990s, and it got good news that sent its shares higher Friday morning.